{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:20:47Z","timestamp":1790893247597,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.neuropharm.2012.09.008","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T19:22:55Z","timestamp":1348600975000},"page":"29-38","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Metabotropic glutamate 2\/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice"],"prefix":"10.1016","volume":"65","author":[{"given":"Yukio","family":"Ago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Chaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.09.008_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-011-2295-3","article-title":"Activation of metabotropic glutamate 2\/3 receptors attenuates methamphetamine-induced hyperlocomotion and increase in prefrontal serotonergic neurotransmission","volume":"217","author":"Ago","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/syn.20575","article-title":"Role of prefrontal dopaminergic neurotransmission in glucocorticoid receptor-mediated modulation of methamphetamine-induced hyperactivity","volume":"63","author":"Ago","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.neuropharm.2008.08.026","article-title":"Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression","volume":"55","author":"Ago","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib4","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.neuropharm.2011.10.004","article-title":"Lithium attenuates methamphetamine-induced hyperlocomotion and behavioral sensitization via modulation of prefrontal monoamine release","volume":"62","author":"Ago","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-011-2293-5","article-title":"Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized\/castrated mice via both 5-HT reuptake inhibition and \u03c31 receptor activation","volume":"217","author":"Ago","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0173(98)00050-2","article-title":"Metabotropic glutamate receptors: electrophysiological properties and role in plasticity","volume":"29","author":"Anwyl","year":"1999","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S146114571000009X","article-title":"Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors","volume":"13","author":"Bortolozzi","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1017\/S1461145708009760","article-title":"Enhancement of cortical extracellular 5-HT by 5-HT1A and 5-HT2C receptor blockade restores the antidepressant-like effect of citalopram in non-responder mice","volume":"12","author":"Calcagno","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1471-4159.2002.00879.x","article-title":"Studies, using in\u00a0vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine (\u2018ecstasy\u2019)-induced dopamine release and free radical formation in the mouse striatum","volume":"81","author":"Camarero","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib10","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0028-3908(01)00034-X","article-title":"Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2\/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade","volume":"40","author":"Cartmell","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","article-title":"Regulation of neurotransmitter release by metabotropic glutamate receptors","volume":"75","author":"Cartmell","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib12","unstructured":"Chaki, S., Ago, Y., Palucha-Paniewiera, A., Matrisciano, F., Pilc, A. mGlu2\/3 and mGlu5 receptors: potential target for novel antidepressants. Neuropharmacology, in press."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.neuropharm.2003.10.009","article-title":"MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity","volume":"46","author":"Chaki","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0893-133X(01)00234-2","article-title":"Influence of different antidepressant drugs on the effect of chronic variable stress on restraint-induced dopamine release in frontal cortex","volume":"25","author":"Cuadra","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2009.04.017","article-title":"Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety\/depression","volume":"62","author":"David","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1192\/bjp.164.3.365","article-title":"Glucocorticoids and the genesis of depressive illness. A psychobiological model","volume":"164","author":"Dinan","year":"1994","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.biopsych.2006.05.047","article-title":"A\u00a0role for MAP kinase signaling in behavioral models of depression and antidepressant treatment","volume":"61","author":"Duman","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1017\/S1461145711001702","article-title":"mTOR activation is required for the antidepressant effects of mGluR2\/3 blockade","volume":"15","author":"Dwyer","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib20","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.neuropharm.2007.11.002","article-title":"Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test","volume":"54","author":"Gould","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib22","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.biopsych.2008.06.016","article-title":"Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone","volume":"64","author":"Gourley","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0932s49","article-title":"Recapitulation and reversal of a persistent depression-like syndrome in rodents","author":"Gourley","year":"2009","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biopsych.2007.07.016","article-title":"Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression","volume":"63","author":"Gourley","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2004.05.013","article-title":"Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats","volume":"156","author":"Gregus","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000127023","article-title":"Altered hypothalamic\u2013pituitary\u2013adrenocortical regulation in healthy subjects at high familial risk for affective disorders","volume":"62","author":"Holsboer","year":"1995","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2010.08.078","article-title":"Pharmacological characterization of repeated corticosterone injection-induced depression model in rats","volume":"1359","author":"Iijima","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2005.11.019","article-title":"Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor","volume":"168","author":"Johnson","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib29","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1037\/0735-7044.118.6.1365","article-title":"Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats","volume":"118","author":"Kalynchuk","year":"2004","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.neuint.2010.07.011","article-title":"AMPA receptor mediates mGlu 2\/3 receptor antagonist-induced dopamine release in the rat nucleus accumbens shell","volume":"57","author":"Karasawa","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2005.02.032","article-title":"AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist","volume":"1042","author":"Karasawa","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2005.09.058","article-title":"A\u00a0metabotropic glutamate 2\/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell","volume":"393","author":"Karasawa","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neuropharm.2010.10.009","article-title":"Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice","volume":"60","author":"Kawasaki","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2004.12.021","article-title":"Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors","volume":"378","author":"Kawashima","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1192\/bjp.136.2.125","article-title":"Cushing's syndrome, tryptophan and depression","volume":"136","author":"Kelly","year":"1980","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib36","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1124\/jpet.103.052027","article-title":"Group II metabotropic and \u03b1-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)\/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats","volume":"306","author":"Kenny","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0091-3057(01)00625-6","article-title":"Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test","volume":"71","author":"Kitamura","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib38","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.neuropharm.2011.08.034","article-title":"Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists","volume":"61","author":"Koike","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib39","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/11533230-000000000-00000","article-title":"Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists","volume":"24","author":"Krystal","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.npp.1300868","article-title":"Assessment of the dexamethasone\/CRH test as a state-dependent marker for hypothalamic\u2013pituitary\u2013adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study","volume":"31","author":"Kunugi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1471-4159.2001.00083.x","article-title":"5-HT1B autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex","volume":"76","author":"Malagi\u00e9","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib42","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0028-3908(02)00299-X","article-title":"Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus","volume":"43","author":"Martinez-Turrillas","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib43","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/sj.npp.1300507","article-title":"Impoverished rearing environment alters metabotropic glutamate receptor expression and function in the prefrontal cortex","volume":"29","author":"Melendez","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1124\/jpet.104.081521","article-title":"Regulation of extracellular glutamate in the prefrontal cortex: focus on the cystine glutamate exchanger and group I metabotropic glutamate receptors","volume":"314","author":"Melendez","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib45","first-page":"121","article-title":"Response to steroid suppression in major depression on resistant to antidepressant therapy","volume":"11","author":"Murphy","year":"1991","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib46","first-page":"209","article-title":"Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486","volume":"18","author":"Murphy","year":"1993","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2007.04.007","article-title":"Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs","volume":"115","author":"Palucha","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00213-010-1978-5","article-title":"On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039","volume":"212","author":"Pa\u0142ucha-Poniewiera","year":"2010","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib49","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bcp.2007.09.021","article-title":"Mood disorders: regulation by metabotropic glutamate receptors","volume":"75","author":"Pilc","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0193-953X(05)70006-X","article-title":"Psychoneuroendocrinology of depression. Hypothalamic\u2013pituitary\u2013adrenal axis","volume":"21","author":"Plotsky","year":"1998","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib51","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1017\/S1461145711000356","article-title":"Beneficial behavioural and neurogenic effects of agomelatine in a model of depression\/anxiety","volume":"15","author":"Rainer","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0022-3565(24)29296-X","article-title":"Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system","volume":"299","author":"Schoepp","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2007.08.006","article-title":"Blockade of the metabotropic glutamate 2\/3 receptors enhances social memory via the AMPA receptor in rats","volume":"575","author":"Shimazaki","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib54","first-page":"485","article-title":"Prolonged treatment of Cushing's disease with metyrapone and aminoglutethimide","volume":"14","author":"Sonino","year":"1986","journal-title":"IRCS J. Med. Sci."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejphar.2008.07.005","article-title":"Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding","volume":"592","author":"Sugimoto","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib56","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1073\/pnas.052712799","article-title":"Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac)","volume":"99","author":"Svenningsson","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1046\/j.1471-4159.2003.02125.x","article-title":"The mGlu2\/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex","volume":"88","author":"Swanson","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib58","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0028-3908(01)00147-2","article-title":"Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523","volume":"41","author":"Tottori","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1254\/jphs.10191FP","article-title":"Pharmacological interaction with the sigma1 (\u03c31)-receptor in the acute behavioral effects of antidepressants","volume":"115","author":"Villard","year":"2011","journal-title":"J.\u00a0Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/187152707780363302","article-title":"Metabotropic glutamate receptors in the control of mood disorders","volume":"6","author":"Witkin","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib61","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S1734-1140(11)70716-2","article-title":"NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice","volume":"63","author":"Wla\u017a","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib62","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1176\/ajp.150.5.810","article-title":"Ketoconazole administration in hypercortisolemic depression","volume":"150","author":"Wolkowitz","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.300.1.162","article-title":"Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens","volume":"300","author":"Xi","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbrc.2004.01.073","article-title":"Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039","volume":"315","author":"Yoshimizu","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00213-006-0390-7","article-title":"An mGluR2\/3 antagonist, MGS0039, exerts antidepressant and anxiolytic effects in behavioral models in rats","volume":"186","author":"Yoshimizu","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.09.008_bib66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejphar.2007.12.005","article-title":"A\u00a0mouse model of depression induced by repeated corticosterone injections","volume":"581","author":"Zhao","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.09.008_bib67","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","article-title":"Hyperactivity and impaired response habituation in hyperdopaminergic mice","volume":"98","author":"Zhuang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812004807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812004807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:38:52Z","timestamp":1744198732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812004807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":67,"alternative-id":["S0028390812004807"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.09.008","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}